Target currently has five product recalls active, after the U.S. Food and Drug Administration ( FDA) terminated a recall of ...
Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...
6don MSN
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings ...
In the month since President Donald Trump returned to the White House, the federal government has undergone a period of unprecedented change. Aided by Elon Musk, the world’s richest man and head of ...
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
A new laboratory study has provided insights into the potential therapeutic benefits of blood purification for patients with metastatic pancreatic duc ...
Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million ...
U.S. stock futures were little changed on Thursday night after the major averages slid following a lackluster earnings ...
Q4 2024 Earnings Call Transcript February 20, 2025 Prothena Corporation plc misses on earnings expectations. Reported EPS is ...
--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American ... Following the U.S. Food and Drug Administration’s (FDA) go-ahead to conduct the Registration Study, CEL-SCI finalized the clinical ...
In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results